Imagen de Portada
Código QR

JAAD Game Changer: A phase 2 study of oral difelikefalin in subjects with chronic kidney disease and moderate-to-severe pruritus.

Publicado en:Journal of the American Academy of Dermatology Vol. 95; no. 3; pp. 929 - 930
Autor principal: Brodell, Robert T.
Formato: Journal Article
Publicado: Elsevier B.V. Sep2026
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=196091311&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 196091311
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        01909622
        1ZF
      jtl: Journal of the American Academy of Dermatology
      issn: 01909622
      maglogo: N
    pubinfo:
      dt: Sep2026
      vid: 95
      iid: 3
      pid: 467
      pub: Elsevier B.V.
      place: New York, New York
    artinfo:
      ui:
        196091311
        10.1016/j.jaad.2026.06.040
        196091311
      ppf: 929
      ppct: 1
      formats:
      tig:
        atl: JAAD Game Changer: A phase 2 study of oral difelikefalin in subjects with chronic kidney disease and moderate-to-severe pruritus.
      aug:
        au: Brodell, Robert T.
      sug:
      pubtype: Academic Journal
      doctype: Journal Article
      ougenre: Article
      ab:
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N